[Asia Economy Reporter Onyu Lim] Zenen Bio announced on the 13th that the largest shareholder will change from the existing Kim Seong-ju to Genexine Co., Ltd. due to the conversion of convertible bonds into common stock. After the change, the largest shareholder's stake will be 8.13%.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing